Stocks and Investing
Stocks and Investing
Fri, July 21, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, July 20, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, July 19, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Christopher Raymond Upgraded (VRTX) to Buy on, Jul 19th, 2017
Christopher Raymond of Raymond James, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy on, Jul 19th, 2017.
Christopher has made no other calls on VRTX in the last 4 months.
There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Christopher's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Christopher
- Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $155 on, Tuesday, July 11th, 2017
- Alan Carr of "Needham" Upgraded from Hold to Strong Buy on, Friday, June 23rd, 2017
- Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy on, Friday, June 2nd, 2017
- Do Kim of "BMO Capital" Upgraded from Hold to Buy on, Wednesday, March 29th, 2017
Contributing Sources